Microglial transcriptomics meets genetics: new disease leads
- PMID: 35228701
- DOI: 10.1038/s41582-022-00633-w
Microglial transcriptomics meets genetics: new disease leads
Erratum in
-
Publisher Correction: Microglial transcriptomics meets genetics: new disease leads.Nat Rev Neurol. 2022 Apr;18(4):249. doi: 10.1038/s41582-022-00643-8. Nat Rev Neurol. 2022. PMID: 35260818 No abstract available.
Comment on
-
Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies.Nat Genet. 2022 Jan;54(1):4-17. doi: 10.1038/s41588-021-00976-y. Epub 2022 Jan 6. Nat Genet. 2022. PMID: 34992268 Free PMC article.
References
-
- Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease. Nat. Genet. 53, 1276–1282 (2021). - DOI
-
- Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183 (2016). - DOI
-
- de Paiva Lopes, K. et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat. Genet. 54, 4–17 (2022). - DOI
-
- Young, A. M. H. et al. A map of transcriptional heterogeneity and regulatory variation in human microglia. Nat. Genet. 53, 861–868 (2021). - DOI
-
- Gerrits, E. et al. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease. Acta Neuropathol. 141, 681–696 (2021). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources